Oxidatively modified high density lipoprotein promotes inflammatory response in human monocytes-macrophages by enhanced production of ROS, TNF-α, MMP-9, and MMP-2

Molecular and Cellular Biochemistry

Volumn 366, Issue 1-2, 2012, Pages 277-285

  Soumyarani, V S ^a   Jayakumari, N ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Inflammation; MMPs; Oxidized HDL; ROS; TNF

Indexed keywords

COPPER SULFATE; GELATIN; GELATINASE A; GELATINASE B; LIPID PEROXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; HEART PROTECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MONOCYTE; OXIDATIVE STRESS; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; ULTRACENTRIFUGATION; ZYMOGRAPHY;

ATHEROSCLEROSIS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPID METABOLISM; LIPOPROTEINS, HDL; MACROPHAGES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MONOCYTES; ORPHAN NUCLEAR RECEPTORS; OXIDATION-REDUCTION; OXIDATIVE STRESS; POLYISOPRENYL PHOSPHATES; REACTIVE OXYGEN SPECIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862006631     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-012-1306-y     Document Type: Article

References (47)

1. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB (1986) Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256:2835-2838 (Pubitemid 17178361)
2. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the veterans affairs high-density lipoprotein intervention trial. Am J Cardiol 86:19L-22L
3. Norata GD, Catapano AL (2005) Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 1:119-129
4. Florentin M, Liberopoulos EN, Wierzbicki AS, Mikhailidis DP (2008) Multiple actions of high-density lipoprotein. Curr Opin Cardiol 23:370-378 (Pubitemid 351787103)
5. Barter PJ, Baker PW, Rye KA (2002) Effect of high-density lipoproteins on the expression of adhesion molecules in endothelial cells. Curr Opin Lipidol 13:285-288 (Pubitemid 34592285)
6. Navab M, Anantharamaiah GM, Fogelman AM (2005) The role of high-density lipoprotein in inflammation. Trends Cardiovasc Med 15:158-161 (Pubitemid 41138881)
7. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342-374 (Pubitemid 44394906)
8. Ansell BJ, Fonarow GC, Fogelman AM (2007) The paradox of dysfunctional high-density lipoprotein. Curr Opin Lipidol 18:427-434 (Pubitemid 47051922)
9. Ansell BJ, Fonarow GC, Fogelman AM (2006) High-density lipoprotein: is it always atheroprotective? Curr Atheroscler Rep 8:405-411 (Pubitemid 44340185)
10. Bai H, Liu BW, Deng ZY, Shen T, Fang DZ, Zhao YH, Liu Y (2006) Plasma very-low-density lipoprotein, low-density lipoprotein, and high-density lipoprotein oxidative modification induces procoagulant profiles in endogenous hypertriglyceridemia. Free Radic Biol Med 40:1796-1803
11. Zheng L, Nukuna B, Brennan ML, Sun M, Goormastic M, Settle M, Schmitt D, Fu X, Thomson L, Fox PL, Ischiropoulos H, Smith JD, Kinter M, Hazen SL (2004) Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114:529-541 (Pubitemid 39572103)
12. Nakajima T, Origuchi N, Matsunaga T, Kawai S, Hokari S, Nakamura H, Inoue I, Katayama S, Nagata A, Komoda T (2000) Localization of oxidized HDL in atheromatous plaques and oxidized HDL binding sites on human aortic endothelial cells. Ann Clin Biochem 37(Pt 2):179-186 (Pubitemid 30122242)
13. Nagano Y, Arai H, Kita T (1991) High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 88:6457-6461 (Pubitemid 21914965)
14. Salmon S, Maziere C, Auclair M, Theron L, Santus R, Maziere JC (1992) Malondialdehyde modification and copper-induced autooxidation of high-density lipoprotein decrease cholesterol efflux from human cultured fibroblasts. Biochim Biophys Acta 1125:230-235
15. Suc I, Brunet S, Mitchell G, Rivard GE, Levy E (2003) Oxidative tyrosylation of high density lipoproteins impairs cholesterol efflux from mouse J774 macrophages: role of scavenger receptors, classes A and B. J Cell Sci 116:89-99 (Pubitemid 36113968)
16. Undurti A, Huang Y, Lupica JA, Smith JD, DiDonato JA, Hazen SL (2009) Modification of high density lipoprotein by myeloperoxidase generates a pro-inflammatory particle. J Biol Chem 284:30825-30835
17. Assinger A, Koller F, Schmid W, Zellner M, Babeluk R, Koller E, Volf I (2010) Specific binding of hypochlorite-oxidized HDL to platelet CD36 triggers proinflammatory and procoagulant effects. Atherosclerosis 212:153-160
18. Francis GA, Mendez AJ, Bierman EL, Heinecke JW (1993) Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proc Natl Acad Sci USA 90:6631-6635 (Pubitemid 23207267)
19. Wang WQ, Merriam DL, Moses AS, Francis GA (1998) Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers. J Biol Chem 273:17391-17398 (Pubitemid 28355066)
20. Girona J, La Ville AE, Heras M, Olive S, Masana L (1997) Oxidized lipoproteins including HDL and their lipid peroxidation products inhibit TNF-alpha secretion by THP-1 human macrophages. Free Radic Biol Med 23:658-667 (Pubitemid 27287349)
21. Pirillo A, Uboldi P, Pappalardo G, Kuhn H, Catapano AL (2007) Modification of HDL3 by mild oxidative stress increases ATP-binding cassette transporter 1-mediated cholesterol efflux. Cardiovasc Res 75:566-574 (Pubitemid 47080967)
22. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
23. Ren J, Jin W, Chen H (2010) oxHDL decreases the expression of CD36 on human macrophages through PPARgamma and p38 MAP kinase dependent mechanisms. Mol Cell Biochem 342:171-181
24. Callegari E, Norata GD, Inoue H, Catapano AL (2006) Oxidized-HDL3 modulates the expression of Cox-2 in human endothelial cells. Int J Mol Med 18:209-213
25. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358 (Pubitemid 9194347)
26. Jovinge S, Ares MP, Kallin B, Nilsson J (1996) Human monocytes/ macrophages release TNF-alpha in response to Ox-LDL. Arterioscler Thromb Vasc Biol 16:1573-1579 (Pubitemid 26427613)
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
28. Zhang M, Gao X, Wu J, Liu D, Cai H, Fu L, Mei C (2010) Oxidized high-density lipoprotein enhances inflammatory activity in rat mesangial cells. Diabetes Metab Res Rev 26:455-463
29. Radhika A, Jacob SS, Sudhakaran PR (2007) Influence of oxidatively modified LDL on monocyte-macrophage differentiation. Mol Cell Biochem 305:133-143 (Pubitemid 47520461)
30. Serra-Perez A, Verdaguer E, Planas AM, Santalucia T (2008) Glucose promotes caspase-dependent delayed cell death after a transient episode of oxygen and glucose deprivation in SH-SY5Y cells. J Neurochem 106:1237-1247
31. Shao B, Oda MN, Oram JF, Heinecke JW (2010) Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. Chem Res Toxicol 23:447-454
32. Rajavashisth TB, Liao JK, Galis ZS, Tripathi S, Laufs U, Tripathi J, Chai NN, Xu XP, Jovinge S, Shah PK, Libby P (1999) Inflammatory cytokines and oxidized low density lipoproteins increase endothelial cell expression of membrane type 1-matrix metalloproteinase. J Biol Chem 274:11924-11929
33. Gough PJ, Gomez IG, Wille PT, Raines EW (2006) Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 116:59-69 (Pubitemid 43121791)
34. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J (2001) Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation 103:926-933 (Pubitemid 32183796)
35. Young JL, Libby P, Schonbeck U (2002) Cytokines in the pathogenesis of atherosclerosis. Thromb Haemost 88:554-567 (Pubitemid 35173995)
36. Napolitano M, Bravo E (2005) Lipid metabolism and TNF-alpha secretion in response to dietary sterols in human monocyte derived macrophages. Eur J Clin Invest 35:482-490 (Pubitemid 41153202)
37. Persson J, Nilsson J, Lindholm MW (2008) Interleukin-1beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells. BMC Immunol 9:70
38. Mei CL, Chen ZJ, Liao YH, Wang YF, Peng HY, Chen Y (2007) Interleukin-10 inhibits the down-regulation of ATP binding cassette transporter A1 by tumour necrosis factor-alpha in THP-1 macrophage-derived foam cells. Cell Biol Int 31:1456-1461
39. Hansson GK, Libby P, Schonbeck U, Yan ZQ (2002) Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 91:281-291 (Pubitemid 34976993)
40. Keller JN, Hanni KB, Kindy MS (2000) Oxidized high-density lipoprotein induces neuron death. Exp Neurol 161:621-630 (Pubitemid 30137019)
41. Hurtado I, Fiol C, Gracia V, Caldu P (1996) In vitro oxidised HDL exerts a cytotoxic effect on macrophages. Atherosclerosis 125:39-46 (Pubitemid 26267120)
42. Thorne RF, Mhaidat NM, Ralston KJ, Burns GF (2007) CD36 is a receptor for oxidized high density lipoprotein: implications for the development of atherosclerosis. FEBS Lett 581:1227-1232 (Pubitemid 46385947)
43. Stadler N, Lindner RA, Davies MJ (2004) Direct detection and quantification of transition metal ions in human atherosclerotic plaques: evidence for the presence of elevated levels of iron and copper. Arterioscler Thromb Vasc Biol 24:949-954 (Pubitemid 38620877)
44. Arroyo LH, Lee RT (1998) The unstable atheromatous plaque. Can J Cardiol 14(Suppl B):11B-13B (Pubitemid 28276700)
45. Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P (2003) Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 9:213-219 (Pubitemid 36227724)
46. Heinecke JW (1998) Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis. Atherosclerosis 141:1-15
47. Fu S, Davies MJ, Stocker R, Dean RT (1998) Evidence for roles of radicals in protein oxidation in advanced human atherosclerotic plaque. Biochem J 333(Pt 3):519-525 (Pubitemid 28398516)